We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$24B
AUM Growth
+$2.89B
Cap. Flow
+$2.75B
Cap. Flow %
11.43%
Top 10 Hldgs %
10.27%
Holding
2,691
New
770
Increased
420
Reduced
344
Closed
817

Sector Composition

Rank Sector Weight
1 Technology 16.54%
2 Financials 12.61%
3 Industrials 10.64%
4 Consumer Discretionary 9.75%
5 Healthcare 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MELI icon
2226
Mercado Libre
MELI
$98.8B
-2,043
Closed -$3.18M
RJET
2227
Republic Airways Holdings
RJET
$879M
-2,133
Closed -$299K
META icon
2228
CALL
Meta Platforms (Facebook)
META
$1.42T
-12,500
Closed -$4.35M
META icon
2229
PUT
Meta Platforms (Facebook)
META
$1.42T
-2,500
Closed -$869K
MFC icon
2230
Manulife Financial
MFC
$71B
-12,038
Closed -$237K
MHK icon
2231
Mohawk Industries
MHK
$9.08B
-91,684
Closed -$17.6M
MHO icon
2232
M/I Homes
MHO
$3.84B
-249,250
Closed -$14.6M
MIDD icon
2233
PUT
Middleby
MIDD
$5.21B
-30,000
Closed -$5.2M
MKC icon
2234
McCormick & Company Non-Voting
MKC
$15.1B
-276,219
Closed -$24.4M
MLKN icon
2235
MillerKnoll
MLKN
$1.58B
-280,023
Closed -$13.2M
MRSH
2236
Marsh
MRSH
$92.9B
-130,652
Closed -$18.4M
MMS icon
2237
Maximus
MMS
$3.05B
-27,861
Closed -$2.45M
MO icon
2238
Altria Group
MO
$114B
-4,466
Closed -$213K
MOH icon
2239
Molina Healthcare
MOH
$10.4B
-26,634
Closed -$6.74M
MPC icon
2240
Marathon Petroleum
MPC
$102B
-185,456
Closed -$11.2M
MRK icon
2241
Merck
MRK
$372B
-353,739
Closed -$26.9M
MRK icon
2242
PUT
Merck
MRK
$372B
-11,000
Closed -$855K
MRNA icon
2243
CALL
Moderna
MRNA
$55.4B
-2,500
Closed -$587K
MS icon
2244
CALL
Morgan Stanley
MS
$336B
-87,500
Closed -$8.02M
MS icon
2245
Morgan Stanley
MS
$336B
-255,688
Closed -$23.4M
MSFT icon
2246
PUT
Microsoft
MSFT
$3.62T
-7,500
Closed -$2.03M
MTCH icon
2247
Match Group
MTCH
$9.58B
-481,794
Closed -$73.4M
MTB icon
2248
M&T Bank
MTB
$34.9B
-93,819
Closed -$13.6M
MTN icon
2249
Vail Resorts
MTN
$5.35B
-42,421
Closed -$13.4M
MTUM icon
2250
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
-57,552
Closed -$9.98M

Similar funds

Dmitry Balyasny's Q3 2021 Portfolio in Review

As of Q3 2021, Dmitry Balyasny held 2,691 positions worth $24B, up 14% from $21.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Dmitry Balyasny deployed $2.75B of net new capital in Q3 2021, opening 770 new positions and adding to 420 existing holdings. Its largest new stake was Salesforce: 556,949 shares worth $151M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Fortive, an estimated $138M trimmed.

  • Dmitry Balyasny's largest Q3 2021 buy was Salesforce: 556,949 shares worth $151M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $537M increase.
  • Dmitry Balyasny's biggest Q3 2021 reduction was Fortive, cutting an estimated $138M.
  • Dmitry Balyasny fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $172M.
  • Dmitry Balyasny's ten largest holdings make up 10% of its $24B portfolio in Q3 2021.
  • Dmitry Balyasny opened 770 new positions and closed 817 in Q3 2021.
  • Dmitry Balyasny's portfolio value rose 14% quarter-over-quarter to $24B.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.